LACMED (5341.KL) stock: key figures, P/E, revenue and dividend
Health Care · Malaysia
LACMED financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 183.22 m MYR | 201.63 m MYR |
| Gross profit | 45.48 m MYR | 58.48 m MYR |
| Operating income | 27.61 m MYR | 31.47 m MYR |
| EBIT | 27.54 m MYR | 31.63 m MYR |
| Net income | 20.40 m MYR | 21.94 m MYR |
| Diluted EPS – continuing operations | 0.05 MYR | 0.05 MYR |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About LACMED
LAC Med Berhad engages in the distribution, supply, and integration of medical devices, diagnostic equipment, and digital health solutions for diagnostic purposes in Malaysia and Indonesia. The company offers diagnostic equipment, radiographic, ultrasound, magnetic resonance imaging (MRI), as well as software systems and maintenance services. It serves hospitals, clinics, and healthcare providers. The company was incorporated in 2003 and is headquartered in Petaling Jaya, Malaysia.
More stocks
- Chunghwa Chemical Synthesis & Biotech Co Ltd (1762.TW)
- Axcen Photonics (6530.TWO)
- Caravel Minerals Ltd (CVV.AX)
- Atlas Energy Public Company Limited (ATLAS.BK)
- Pinetree Capital Ltd (PNP.TO)
- Cell Biotech Co. Ltd (049960.KQ)
- Gigastone Corporation (5262.TWO)
- Global Connections Public Company Limited (GC.BK)
- mPLUS Corp (259630.KQ)
- FNS TECH. Co., Ltd (083500.KQ)
- Outset Medical, Inc. (OM)
- Mobiletron Electronics Co Ltd (1533.TW)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.